Table of Contents
1 Industry Outlook
1.1 Medical Devices Industry
1.1.1 Overview
1.1.2 Facial Aesthetics
1.1.2.1 Facial Aesthetics
1.1.2.2 Botox
1.1.2.3 Dermal Fillers
1.1.2.4 Chemical Peel
1.1.2.5 Microdermabrasion
1.1.3 Materials Used in Soft Tissue Fillers
1.1.3.1 Absorbable Materials
1.1.3.2 Non-absorbable Materials
1.1.4 Industry Trends
1.2 Healthcare Spending
1.2.1 US
1.2.2 Europe
1.3 Regulatory Bodies & Standards
1.4 Emerging Global Markets
1.5 Patient Demographics
1.6 PESTLE Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Opportunity Analysis
3.4 Strategic Initiatives
3.5 Related Markets
3.5.1 Facial Aesthetics Market
3.5.2 Dental Implants Market
3.5.3 Breast Implant Market
3.5.4 Energy-based Aesthetic Devices Market
3.6 Porter 5 (Five) Forces
4 Market Characteristics
4.1 Evolution
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rise in focus on physical appearance to reverse the sign of aging
4.2.1.2 Rising geriatric population
4.2.1.3 Increased preference for minimally invasive cosmetic surgeries
4.2.1.4 Increasing awareness about anti-aging skincare measures
4.2.1.5 Increase in disposable income
4.2.2 Restraints
4.2.2.1 Complications and risks associated with facial injectables
4.2.2.2 High cost of facial injectables
4.2.2.3 Threat of counterfeit products in the market
4.2.2.4 Paucity of skilled professionals
4.2.2.1 Intense competition among vendors
4.2.3 Opportunities
4.2.3.1 Technological advancements
4.2.3.2 Upsurge in medical tourism
4.2.3.3 Increase in the demand for combination treatments
4.2.3.4 Increase in healthcare spending
4.2.4 DRO - Impact Analysis
4.3 Product Type Segmentation - Market Size and Forecast
4.3.1 Dermal Fillers
4.3.1.1 Overview
4.3.2 Featured Products
4.3.3 Botox
4.3.3.1 Overview
4.3.4 Featured Products
4.4 Key Stakeholders
5 End-users
5.1 Overview
5.2 Hospitals
5.3 Dermatology Centers
5.4 Physician's Office
6 Regions
6.1 Overview
6.2 North America
6.2.1 Overview
6.2.2 Market Developments
6.3 Europe
6.3.1 Overview
6.3.2 Market Developments
6.4 APAC
6.4.1 Overview
6.4.2 Market Developments
6.5 Rest of the World
6.5.1 Overview
6.5.2 Market Developments
7 Competitive Landscape
7.1 Competitor Comparison Analysis
7.1.1 Competitiveness
7.1.2 Key Competitive Facts
8 Vendors Profile
8.1 Allergan plc
8.1.1 Overview
8.1.2 Business Units
8.1.3 Business Focus
8.1.4 SWOT Analysis
8.1.5 Business Strategies
8.2 Galderma
8.2.1 Overview
8.2.2 Business Focus
8.2.3 SWOT Analysis
8.2.4 Business Strategies
8.3 Merz Pharma Gmbh & Co. KGaA
8.3.1 Overview
8.3.2 Geographic Presence
8.3.3 Business Focus
8.3.4 SWOT Analysis
8.3.5 Business Strategies
8.4 Ipsen S.A.
8.4.1 Overview
8.4.2 Business Units
8.4.3 Geographic Presence
8.4.4 Business Focus
8.4.5 SWOT Analysis
8.4.6 Business Strategies
9 Companies to Watch For
9.1 Sinclair Pharma Plc
9.1.1 Overview
9.1.2 Business Strategies
9.2 Bloomage BioTechology Corp. Ltd.
9.2.1 Overview
9.2.2 Key Highlights
9.2.3 Business Strategies
9.3 Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International Inc)
9.3.1 Overview
9.3.2 Key Highlights
9.3.3 Business Strategies
10 Other Prominent Vendors
11 Annexure